The Scripps Research Institute v. Cempra Pharmaceuticals, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 THE SCRIPPS RESEARCH Case No.: 3:19-cv-1866-W-AHG
INSTITUTE,
ORDER VACATING EARLY Plaintiff, NEUTRAL EVALUATION
CONFERENCE AND CASE
v. MANAGEMENT CONFERENCE
CEMPRA PHARMACEUTICALS, INC.,
15 et al., 16 Defendants.
18 On December 27, 2019, Defendants Cempra Pharmaceuticals, Inc., Melinta 19 Therapeutics, Inc.,1 and Melinta Subsidiary Corp. filed a Suggestion of Bankruptcy on 20 the record, explaining that each of these Debtor entities has filed for bankruptcy in the 21 United States Bankruptcy Court for the District of Delaware. ECF No. 14. The 22 bankruptcy filings operate as an automatic stay of all judicial actions against those 23 Defendants pursuant to 11 U.S.C. § 362(a). Thus, in light of the automatic stay, the Early 24 Neutral Evaluation Conference (“ENE”) and Case Management Conference (“CMC”) 25 26 27 1 Defendant Melinta Therapeutics, Inc. was formerly known as Cempra, Inc., which is 28 currently scheduled for February 12, 2020 are…